Celldex Therapeutics | CLDX - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
AbbVie USD 9.39B 4.16B 2026-03
Agenus USD 35M 32M 2026-03
Amgen USD 12.04B 2.91B 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Celldex Therapeutics USD 35.73M 6.86M 2026-03
Glaxosmithkline GBP 3.3B 303M 2025-09
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Northwest Biotherapeutics USD 4.56M 244K 2025-09
Pfizer USD 1.7B 561M 2026-03
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Roche Holding CHF 7.55B 579M 2025-06